Complications of bacillus Calmette-Guerin (BCG) immunotherapy in superficial bladder cancer.
Sosnowski
J T
JT
Department of Surgery, College of Medicine, Ohio State University, Columbus.
D000707:Anaphylaxis / Q000209:etiology; D001500:BCG Vaccine / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use*; D002278:Carcinoma in Situ / Q000628:therapy; D002295:Carcinoma, Transitional Cell / Q000628:therapy; D000075202:Contraindications; D003556:Cystitis / Q000209:etiology; D006801:Humans; D012772:Shock, Septic / Q000209:etiology; D001749:Urinary Bladder Neoplasms / Q000628:therapy*
D001500:BCG Vaccine